Napar Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 05-07-2024
- Paid Up Capital ₹ 0.50 M
as on 05-07-2024
- Company Age 11 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.03 Cr
as on 05-07-2024
- Satisfied Charges ₹ 8.70 M
as on 05-07-2024
- Revenue 99.81%
(FY 2023)
- Profit 566.26%
(FY 2023)
- Ebitda 466.84%
(FY 2023)
- Net Worth 201.22%
(FY 2023)
- Total Assets 19.99%
(FY 2023)
About Napar Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹1.03 Cr. The company has closed loans amounting to ₹8.70 M, as per Ministry of Corporate Affairs (MCA) records.
Sonal Paresh and Paresh Chaklasiya serve as directors at the Company.
- CIN/LLPIN
U24231MH2013PTC246971
- Company No.
246971
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
02 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Thane, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Napar Pharmachem Private Limited offer?
Napar Pharmachem Private Limited offers a wide range of products and services, including Aldehydes, Chemical Intermediates, Cyanoacetic Acid, Pharma Ingredients & Raw Materials, Anti Infective API, Industrial Chemicals & Supplies, Rubber Chemicals, Chemical Reagents & Catalysts, Halogenating Agent, Dyes & Color Additives.
Who are the key members and board of directors at Napar Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sonal Paresh  | Director | 05-Jan-2019 | Current |
| Paresh Chaklasiya | Director | 14-Aug-2013 | Current |
Financial Performance of Napar Pharmachem.
Napar Pharmachem Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 99.81% increase. The company also saw a substantial improvement in profitability, with a 566.26% increase in profit. The company's net worth Soared by an impressive increase of 201.22%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Napar Pharmachem?
In 2023, Napar Pharmachem had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Jan 2023 | ₹1.03 Cr | Open |
Axis Bank Limited Creation Date: 27 Dec 2019 | ₹6.20 M | Satisfied |
Yes Bank Limited Creation Date: 17 Oct 2017 | ₹2.50 M | Satisfied |
How Many Employees Work at Napar Pharmachem?
Unlock and access historical data on people associated with Napar Pharmachem, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Napar Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Napar Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
